Company intelligence / Profile preview

Coloplast

Humlebæk, Capital Region, Denmarkcoloplast.us ↗

Ownership: Public · COLO B
Employees: ~12000
Development stage: Commercial

Overview

Coloplast’s products are widely used globally for ostomy management, continence management (catheters and related devices), advanced wound healing, interventional urology procedures/devices, and laryngectomy/voice restoration. The company has a strong track record of innovation in these areas but does not conduct pharmaceutical clinical trials as it focuses on medical devices[1][3][5].

Therapeutic areas: GastroenterologyPulmonologyMen's HealthDermatology
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

No major disclosed pharma/biotech partnerships; collaborates with healthcare providers/hospitals globally.

Financials

Market cap: $870.6M
Total revenue: $631.4M
Enterprise value: $1.1B

Beyond the preview

Go deeper on Coloplast.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Coloplast.

Explore the full profile